Sanity Group

Large global tobacco companies are investing in and partnering with cannabis companies with eyes set on future growth for the sector. Industry experts shared the reasons why the cannabis sector is attractive to tobacco companies during the 2025 Benzinga Cannabis Capital Conference in Chicago....

France maintains one of the strictest cannabis policies in Europe, prohibiting recreational use, possession and cultivation. Paradoxically, it also has the highest cannabis consumption rate on the continent. As the French government grapples with mounting public debt –currently at 112% of GDP–...

Even though Germany partially legalized cannabis on April 1, allowing people over 18 to possess up to 25 grams of dried cannabis and cultivate up to three plants at home, most marijuana consumed still comes from the black market. The reason for this could be a combination of the slow roll-out of...

The Benzinga Cannabis Capital Conference brought together global cannabis leaders, including Finn Hänsel, managing director and founder of Sanity Group. Sanity Group is one of the leading cannabis companies in Germany, focusing on medicinal cannabis, CBD wellness products, and adult-use cannabis....

In a global cannabis market brimming with potential, where should businesses focus their attention? Experts from the Benzinga Cannabis Capital Conference examined the profitability and growth prospects across Europe, Australia, Southeast Asia, and Canada, with Germany standing out as the market...

In an exclusive reveal to Benzinga Cannabis, Wiz Khalifa just unveiled the latest addition to his cannabis empire: his very own line of rolling papers, adding to his existing products like the popular Khalifa Kush lighters and pre-roll filters. This announcement, made during an in-depth interview...

Khalifa Kush, a cannabis brand founded by multi-platinum-selling, GRAMMY and Golden Globe-nominated recording artist Wiz Khalifa, is coming to Europe. Starting in early 2025, Khalifa Kush will enter the German medical cannabis market through a strategic multi-year partnership with Berlin-based...

The first data recorded from a pilot study on the controlled dispensing of recreational cannabis in the canton of Basel-Landschaft are now available. This study, named the "Grashaus Projects," is one of seven approved by the Swiss Federal Office of Public Health (FOPH). The primary objective of...

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced on Tuesday a strategic investment aimed at expanding its presence within the burgeoning European cannabis market. What Happened The Toronto-based company will utilize proceeds from its Jupiter strategic investment pool and invest €14 million...

Sanity Group is leading a change in the perception and regulation of cannabis across Europe. Centering on the untapped potential of cannabinoids for health, the company based in Berlin is bridging historical misconceptions with modern recognition of cannabis’s benefits. Dual Approach:...

Even though the European cannabis scene has not yet witnessed unexpected large-scale shifts, markets like the U.K., Germany, Denmark, Portugal and the Netherlands have been growing in terms of diversity of products and players. While Canadian cannabis giants like Canopy Growth Corporation (NASDAQ:...

In the latest episode of Benzinga’s Cannabis Insider podcast, hosts Abbey Higginbotham and Pato Liddle interviewed Raj Grover, CEO of High Tide Inc (NASDAQ:HITI), and Finn Hänsel, CEO of Sanity Group. In this exclusive conversation, these industry leaders discussed their vision for the future...

In a groundbreaking move, the Swiss Federal Office of Public Health (BAG) has granted approval to the Swiss Institute for Addiction and Health Research (ISGF) and the Sanity Group to initiate a pilot study on the controlled dispensing of recreational cannabis in the canton of Basel-Landschaft. This...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has expanded its global footprint by entering into a supply agreement to provide dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has entered into a supply agreement for dried flower with the medical division of German cannabis company Sanity Group. Through exports from its cultivation facility in Moncton, Organigram already services medical patients in Israel and Australia,...